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1. Introduction 
Volume management is an important aspect of caring for patients with sepsis. Multiple 
factors contribute to the challenge of resuscitating septic patients, including volume 
depletion, a decrease in vascular tone and myocardial depression. Goal directed therapy 
incorporates the use of physiologic targets to guide fluid resuscitation in this population, 
taking into account the changes in physiology of a patient with sepsis. Further, evolving 
technology and knowledge is allowing for a better understanding of endpoints when 
managing fluids in this critically ill patient group. 
Patient’s presenting with hypo-perfusion secondary to septic shock benefit from early, 
aggressive resuscitation in a protocolized manner (Rivers, 2001). The goals of initial 
resuscitation, to be achieved within 6 hours of presentation, include a central venous 
pressure of 8 – 12 mmHg, mean arterial pressure (MAP) of ≥ 65 mmHg, urine output ≥ 0.5 
mL/kg/hr and a central venous (ScvO2) or mixed venous oxygen saturation ≥ 70% or 65%, 
respectively (Rivers 2001, Dellinger, 2008). This concept is known as early goal directed 
therapy (EGDT) (Rivers, 2001).  
1.1 Oxygen delivery 
The ultimate goal of early resuscitation is to achieve adequate oxygen delivery so the 
balance between supply and demand to vital organs is maintained. A critical level of oxygen 
delivery (DO2) exists for septic patients and increasing the DO2 above that level does not 
further increase oxygen consumption. (Ronco, 1993; Shibutani, 1983;, Danek, 1980; Nelson, 
1987, 1988)  When below critical DO2, oxygen utilization is dependent upon DO2 (Figure 1), 
compensation via increased oxygen extraction is no longer sufficient, oxygen debt develops 
and anaerobic metabolism ensues. (Pieracci, 2011) One accepted method to measure 
whether DO2 is above this threshold involves determining the oxygen saturation of venous 
blood returning to the heart (McGee & Jodka, 2002; Krafft, 1993). ScvO2 as a proxy for SVO2 
is reasonable (Lee, 1972; Reinhart, 2004; Ladakis, 2001) and reflects the oxygen saturation of 
SVC blood. As the saturation of venous blood (Figure 2) declines, oxygen consumption is 
increasing for a constant value of oxygen delivery, or oxygen delivery itself may be 
declining. In either circumstance assessment of ScVO2 represents the balance between 
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delivery and consumption simultaneously and can be measured continuously alerting the 
clinician to reassess the components of both delivery and consumption. Critical imbalances 
often require acute intervention to assure survival and prevent organ dysfunction. Lower 
values are the result of increased oxygen extraction at the tissue level typically due to 
decreased oxygen delivery (DO2) and values <70% suggest tissue hypoperfusion. If the 
ScVO2 drops below 50% there is an increased risk of developing anaerobic metabolism and 
lactic acidosis. (Simmons, 1978) Low or declining ScVO2 indicates further manipulation of 
DO2 or less commonly VO2 may be necessary to assure adequate cellular oxygenation. 
(Rivers, 2001; Lee, 1972; Kasnitz, 1976; Reinhart, 1989) 
 
 
Fig. 1. 
1.2 Therapeutic targets 
Multiple studies demonstrated the survivors of high stress situations induced by surgery, 
sepsis, trauma or cardiac insults achieved a higher cardiac index, oxygen delivery (DO2) 
and oxygen consumption (VO2) as compared to non-survivors (Heyland, 1996; Shoemaker, 
1993, Bishop, 1993; Shoemaker, 1993; Edwards, 1989; Gilbert, 1986; Shoemaker, 1993; 
Creamer, 1990; Hankein, 1991; Hayes, 1993; Kankein, 1987; Cryer, 1989). As a result of these 
findings, efforts were made to target these variables in an effort to improve outcomes of the 
critically ill. The first randomized, controlled trial (Shoemaker, 1988) implemented protocols 
to generate supraphysiologic values as therapeutic goals in high risk surgical patients. 
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Patients with oxygen transport maximized by a PA catheter protocol had a lower mortality, 
reduced duration of mechanical ventilation and ICU stay. Study limitations in baseline 
characteristics of the various groups along with an unblinded design raise the question of 
bias versus an actual treatment impact (Shoemaker, 1988; Heyland, 1996).  
 
 
Fig. 2. 
Hayes et al (Hayes, 1994) randomly assigned patients failing to reach established 
therapeutic goals following volume resuscitation alone to continue with standard care or 
receive dobutamine to increase cardiac index, oxygen delivery and oxygen consumption. 
The treatment group had a higher mortality, suggesting efforts to achieve supranormal 
physiologic targets may result in more risk than benefit. In addition, Gattinoni et al 
(Gattinoni, 1995) failed to demonstrate a favorable impact on morbidity or mortality when 
targeting hemodynamic therapy to achieve supranormal values for cardiac index or normal 
values for mixed venous oxygen saturation. 
In 2001, Rivers et al (Rivers, 2001) published the results of a randomized trial of EGDT in the 
treatment of patients with severe sepsis and septic shock. By instituting a multi-faceted 
protocol targeted to increase oxygen delivery they were able to demonstrate significant 
benefits to outcome in this patient population. The main components of this approach 
included continuous monitoring of central venous oxygen saturation (ScvO2), treatment in a 
dedicated area of the emergency department for the first six hours and fluid boluses to 
achieve a central venous pressure (CVP) of 8 to 12 mmHg. If the MAP remained < 65 mmHg 
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following fluid resuscitation to a CVP of 8 – 12 mmHg, vasopressor therapy began, red 
blood cells were transfused to achieve a hematocrit of at least 30% if the ScvO2 was less than 
70% and dobutamine administration titrated to achieve an ScvO2 of at least 70% despite the 
other interventions. (Rivers, 2001) The intervention group was more likely to achieve the 
ScvO2, CVP, MAP and urine output goals along with an improvement in mortality. 46.5% in 
those receiving standard therapy died compared to 30.5% in the EGDT cohort (p=0.009). The 
EGDT group also received significantly more fluid (4981 mL vs. 3499 mL), red blood cells 
(64.1% transfused vs. 18.5%), and inotropic support (13.7% vs. 0.8%) during the first 6 hours. 
The difference in fluid balance did not persist at 72 hours (13,443 mL in EGDT vs. 13,358 in 
standard therapy) emphasizing the importance of rapid volume optimization for septic 
shock. (Rivers, 2001) This study demonstrated for the first time the importance of an 
aggressive, early, protocolized, goal directed treatment regimen in caring for patients with 
severe sepsis and septic shock. This protocol has been adopted in multiple guidelines as the 
standard of care for treating septic patients (Dellinger, 2008). Table 1 summarizes the 
findings of the above trials.  
 
Study Intervention Results 
Shoemaker, 1988 Supraphysiologic values as 
therapeutic goals in high risk surgical 
patients 
Oxygen transport 
maximized by a PA 
catheter protocol lead to 
lower mortality, reduced 
duration of mechanical 
ventilation and shorter ICU 
stay 
Hayes, 1994 Dobutamine to increase cardiac 
index, oxygen delivery and oxygen 
consumption 
Higher mortality in 
patients treated with 
dobutamine compared to 
standard care 
Gattinoni, 1995 Achieving supranormal values for 
cardiac index or normal values for 
mixed venous oxygen saturation 
No improvement on 
morbidity or mortality 
Rivers, 2001 Early goal directed therapy with CVP 
of 8 – 12 mmHg, vasopressors if MAP 
< 65 mmHg following fluid 
resuscitation, ScvO2 ≥ 70%, 
dobutamine and red blood cells to 
keep hematocrit at least 30% if ScvO2 
< 70% 
Improved mortality with 
intervention compared to 
standard care. More fluid, 
red blood cells and 
inotropic support during 
first 6 hours in intervention 
group. 
Table 1. Summary of Studies on Goal Directed Therapy 
1.3 Physiological derangements 
Aggressive fluid resuscitation is a mainstay of therapy for septic patients as this population 
tends to be severely hypovolemic related to multiple mechanisms, venodilation from altered 
vascular tone leads to pooling of blood in the capacitance vessels. (McGee & Jodka. 2002; 
Kumar, 2009, Teule 1984) Septic patients also have extravasation of fluid into the 
interstitium related to increased permeability of the capillary endothelium (Rivers 2008; 
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Pieracci 2011). These phenomena result in decreased preload, cardiac output and inadequate 
oxygen delivery. It remains essential to restore volume status and improve cardiac 
performance. Additionally, the body’s inflammatory response is further modulated by 
cellular hypoxia brought about by the decline in bulk oxygen delivery (Rivers, 2007) may 
compound the physiologic derangement. 
Concurrent with the needs to restore adequate preload and circulating blood volume, septic 
patients often demonstrate myocardial depression. This dysfunction is related to the 
presence of myocardial depressant factors early in the septic process, not decreased 
myocardial perfusion, and include cytokines, tumor necrosis factor alpha (TNF-ǂ) and 
interleukin one beta (IL-1ǃ) acting synergistically. (Court, 2002; Pathan, 2002) Additionally, 
nitric oxide generation, interstitial myocarditis, calcium trafficking, endothelin receptor 
antagonists and apoptosis likely all contribute to the ongoing process of myocardial 
depression. (Fernandes, 2008). This is manifest as a low cardiac output concurrent with a 
decrease in ejection fraction and oxygen delivery despite adequate filling pressures. 
Ventricular interdependence and impairment of left ventricular filling may be an important 
concern especially with concomitant ARDS and RV dysfunction/dilatation.  (Michard, 2010; 
von Ballmoos, 2010) 
The use of echocardiogram plays an important role in quantifying the degree of dysfunction 
as it is used to assess biventricular contractility and identifies hemodynamically unstable 
patients who will benefit from either inotropic support or further volume expansion 
(Griffee, 2010; Beaulieu, 2007).  Dobutamine is a typical first line inotropic agent when 
myocardial depression of sepsis is confirmed and the goal is to establish adequate oxygen 
delivery or tissue perfusion as measured by ScvO2. No benefit is seen using inotropes to 
create a supra-physiologic state though studies achieving this did not have echocardiogram 
data to determine what proportion of subjects had impaired contractility (Hayes, 1994; 
Gattinoni, 1995). Sepsis induced myocardial depression usually resolves completely over the 
course of the illness for survivors. (Griffee, 2010; Parker, 1984). 
1.4 Role of red blood cells 
Controversy exists as to the ideal hemoglobin concentration for septic patients undergoing 
EGDT as the risks of transfusion often outweigh the benefits. (Hebert, 1999; Marik, 2008; 
Fuller, 2010) The goal of transfusion of red blood cells is to improve DO2. There is no impact 
on the sublingual microcirculation as detected by an orthogonal polarization spectral device 
in septic patients receiving a red blood cell transfusion (Sakr, 2007). Further, transfusing 
anemic, septic patients does not improve either regional or global oxygen utilization as 
determined by either the Fick equation or indirect calorimetry and may increase pulmonary 
vascular resistance, further hindering right ventricular function. (Fernandes, 2001; Bone, 
1993) At this time unless there is active myocardial ischemia, it is difficult to define exact 
triggers for transfusion of red blood cells in septic patients undergoing active resuscitation. 
(Pieracci, 2011) 
1.5 Avoiding volume overload 
An aggressive, early intervention targeted at improving hemodynamic performance in 
septic patients improves outcomes and is now recognized as the standard of care. The 
trigger to transfuse red blood cells during the early resuscitation of septic patients remains 
controversial and is a major criticism of EGDT, especially given the known complications of 
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providing transfusions to critically ill patients. Critical care practitioners need to recognize 
both the importance of implementing EGDT and avoiding the deleterious effects of fluid 
overload. When septic patients have a more positive fluid balance both early in the 
resuscitation process and cumulatively over 4 days there is an associated increased risk of 
mortality (Boyd, 2011). The importance of carefully managing fluids is further illustrated in 
patients with acute lung injury or ARDS as those with a lower cumulative fluid balance 
demonstrate improved outcomes. (Murphy, 2009; the NHLBI ARDSNet, 2006) When 
complicated by acute kidney injury, fluid overload further impacts mortality in critically ill 
patients (Payen, 2008; Bouchard, 2009) 
2. Applied physiology for the management of severe sepsis/septic shock 
The foundation of all resuscitation strategies for severe sepsis and septic shock is volume 
therapy. Early goal directed therapy is complicated by the requirement for central venous 
access which is not always available especially during the initial patient evaluation, and 
the use of a CVP target which has been called in to question as a meaningful measure of 
preload responsiveness. (Michard, 2002; Marik, 2008;Osman, 2007) Additionally although 
rapid resuscitation is important excess volume that does not improve cardiac performance 
is potentially contributing to complications; excess length of stay (Wiedemann, 2006) and 
mortality (Murphy, 2009). Generally as the goal of any volume therapy in the critically ill 
is to improve cardiac performance, we propose physiology based hemodynamic therapy 
for the severely septic patient that considers the pathophysiology already described.  
2.1 Physiologic optimization program for sepsis resuscitation, dynamic variables of 
volume responsiveness 
Utilizing dynamic variables of volume responsiveness to guide resuscitation allows precise 
titration of preload with clear endpoints for fluid resuscitation to minimize the risk of 
inappropriate fluid overload. Dynamic variables of volume responsiveness, stroke volume 
variation (SVV) and pulse pressure variations (PPV) exploit the physiology of the 
heart/lung interaction during positive pressure ventilation that relates the variation of 
stroke volume or pulse pressure to the degree of volume responsiveness. The respirophasic 
change in blood pressure (commonly observed in the arterial pressure tracing) of 
hypovolemic patients is a well known example. (McGee, 2009) (Figure 3). 
The available devices quantify the variability and display the variation as a primary output. 
This variation is highly correlated with the degree of volume responsiveness, i.e., the greater 
the variation, the greater the expected response to a volume challenge. (Figure 4). 
This approach is available only for patients with controlled positive pressure ventilation 
without a significant dysrhythmia as the utility of SVV or PPV to assess volume 
responsiveness is not valid beyond these conditions. The use of the dynamic variables SVV 
and PPV, especially during early resuscitation prior to intubation is generally not possible. 
Resuscitation of these patients, however, is straight forward and relies on titration of 
volume against cardiac performance measured by SV and CO. This approach provides 
assurance that preload optimization has occurred prior to implementation of 
pharmacotherapy. Our preference is to use the indexed values in an attempt to normalize 
targets across variability in body surface area. This may be problematic in the super obese 
(McGee, 2006). (Figure 5). 
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Fig. 3. The phasic change in blood pressure and its timing to the ventilatory cycle is 
illustrated with four positive pressure breaths and the simultaneously displayed arterial 
waveform directly below it. Blood pressure goes up during the inspiratory phase of 
mechanical ventilation and decreases during expiration. The swings in blood pressure 
(pulse pressure variation, PPV) are generated by the change in stroke volume SV (stroke 
volume variation, SVV) effected by positive pressure ventilation. The variability is 
respirophasic as this figure illustrates. The impact on right (RV) and left ventricular (LV) pre 
and afterload induced by positive pressure ventilation is shown. 
In those clinical settings where SVV or PPV does not predict volume responsiveness how 
can this be determined? As long as stroke volume can be measured this question can be 
answered. This represents a huge advantage of the technologies that allow measurement of 
stroke volume and cardiac output, FloTrac/Vigileo, PICCO, and LiDCO, over those that 
simply provide pulse pressure variation, which is now readily available on bedside 
monitors that display an arterial waveform (IntelliVue MP90, 2006). This physiology also 
explains why this literature has been primarily developed in the operating room where ideal 
conditions often exist for the measurement and application of dynamic parameters, namely 
controlled mechanical ventilation with a large enough tidal volume to induce a significant 
change in pleural pressure to impact venous return. A threshold value for tidal volume of 8 
cc per kilogram ideal body weight has been determined in several studies that evaluated the 
tidal volume necessary to meaningfully impact venous return. (Feissel, 2001; Tavernier, 
1998; Michard, 2000; Perel, 1987) Across a heterogeneous population, this may be true, 
although there will be specific examples depending on the patient’s lung compliance and 
intravascular volume status where it may not be.  
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Fig. 4. Legend: A and B represent different locations on the Starling Curve. The change in 
preload induced by the ventilator is identical. The impact on SV is not. The change in SV 
induced by one positive pressure breath is proportional to SVV. SVV determines the 
magnitude of preload dependency. Patients with higher SVV are more volume responsive 
(A – preload dependent) functioning on the steeper portion of the Frank Starling curve. SVV 
decreases as preload dependent LV function is optimized (B – preload independent). In 
these patients (B) volume can be safely removed as cardiac performance is not influenced by 
changes in preload. SVV/SVI pairs allow individual discrimination of a patient’s Starling 
curve that can determine when volume is required to improve cardiac performance and 
conversely when volume can be safely removed. SV (stroke volume) SVV (stroke volume 
variation) 
At lower tidal volumes, false negatives where stroke volume variation is low, and the 
patient is still significantly volume responsive occur. Extreme examples of this were 
encountered during the H1N1 flu epidemic in the fall of 2009, where many patients were 
being oscillated at very high frequencies but with minimal tidal volume and hence pleural 
pressure change. These patients could be significantly volume responsive with essentially 
no stroke volume or pulse pressure variation because of the very small change in pleural 
pressure induced with this strategy of ventilation. Similarly, patients being ventilated using 
a low tidal volume strategy for ALI/ARDS may manifest a similar phenomenon. In those 
patients, teasing out volume responsiveness utilizing physiology is fairly simple. Listed 
below are three possible strategies to ascertain volume responsiveness when SVV is unable 
to provide direction: (DeBacker, 2005) 
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Fig. 5. The goal of volume therapy during resuscitation is to optimize the use of preload 
augmentation of cardiac function. Stroke volume variation is a very useful parameter to 
allow rapid safe resuscitation. When this parameter is not useful (dysrhythmia, small tidal 
volume, spontaneous breathing), simply targeting the maximum stroke volume index (SVI), 
is another means to guide volume therapy. Independent of which Frank-Starling Curve the 
patient is on ,the goal of volume therapy is always the same during resuscitation; to obtain 
the most benefit from the preload dependent portion of the Frank-Starling Curve. These 
techniques have the additional benefit of more precisely targeting the “sweet spot” of the 
Frank-Starling Curve without excessive volume overload. 
2.2 Stroke volume index targeted resuscitation: Obtaining the sweet spot on the 
Frank-Starling curve (figure 5) 
1. Recruitable stroke volume: 
Increase the tidal volume to at least 8-10 cc/kg and look for the change in SVV.  For volume 
responsive patients, once beyond a threshold value for tidal volume, volume responsiveness 
becomes apparent as the SVV will increase to greater than 10-13%, a reliable cutoff above 
which patients are generally volume responsive. The time responsiveness of these 
technologies is fairly rapid and tidal volume needs to be increased for only a short period of 
time, typically less than 5 minutes. Physician presence at the bedside during this maneuver 
is important to: 
a. View the change; and 
b. Assure that the pressure encountered with the ventilation change is not harmful to the 
patients. If this change in tidal volume results in SVV becoming greater than 10-13%, a 
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fluid bolus is then given after the patient has been returned to the initial ventilator 
settings. 
Two additional strategies are also useful for non-ventilated patients or those with significant 
dysrhythmias. 
2. The passive leg raising maneuver (PLR) ((Cavallaro, 2010, Monnet, 2006) (Figure 6.) 
 
Passive Leg Raising
Baseline PLR
Data recorded after 
120s
Patients who respond to the PLR maneuver will also 
respond to a fluid bolus. Response described in text.
 
Fig. 6. 
The patient is placed flat and the legs are elevated to 45 degrees and the change in stroke 
volume and cardiac output is recorded. Those patients that have a positive response usually 
defined as greater than 12-15% increase in cardiac output are then given a fluid challenge, 
typically 250-500 cc of colloid or crystalloid. This can be done numerous times until the 
indicator of volume responsiveness disappears or an adequate stroke volume/cardiac 
output is reached. Although the change in SV using aortic flow is fully apparent within 30 
seconds, the increase in venous return that this maneuver induces in cardiac performance 
requires the legs be elevated for roughly 120 seconds to allow for the time constraints of the 
pulse contour technology. (Teboul, 2009; Biais, 2009) In numerous studies, this has been 
shown to be essentially a perfect test as a measure of volume responsiveness as long as the 
improvement in stroke volume/cardiac output is the cardiac performance parameter of 
interest. (Cavallaro, 2010) Simply looking at the change in blood pressure is not helpful. 
(Monnet, 2006) This technique works well especially in those patients who are either 
spontaneously breathing or have a significant dysrhythmia. This reversible volume 
challenge is most useful in patients with acute lung injury or ARDS or those with either 
acute or chronic renal failure, where giving a volume challenge that does not result in 
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improvement in cardiac performance may in fact be detrimental to the patient. (Cavallaro, 
2010; McGee, 2009) 
3. Volume challenges: As long as there is a cardiac performance measure, stroke volume 
or cardiac output, simply giving a fluid bolus and assessing its impact on cardiac 
performance is a reasonable way to assess volume responsiveness for patients where 
we suspect that additional volume will not be injurious, i.e. clear lungs and without 
renal failure. If cardiac performance does not improve, volume is not the correct 
therapy (Figure 5). 
It is important to recognize when the patient is on the flat part of the Frank-Starling  
Curve and not responding to volume. Excess volume therapy has been associated with 
increased length of stay, increased time on mechanical ventilation, and mortality.  
(Boyd, 2011; Murphy, 2009; the NHLBI ARDSNet, 2006; Payen, 2008;Bouchard, 2009; 
Maitland, 2011) The major impact of using these technologies well is that we now have  
the ability for precise titration of volume management in the majority of critically  
ill patients. The simple premise underlying volume therapy in the ICU or OR is to affect  
a change in cardiac performance. This simply is not possible without a cardiac 
performance measure.  
2.3 Physiologic optimization program (figure 7) 
Figure 7 illustrates the use of dynamic parameters of volume responsiveness for the 
hemodynamic management of patients with severe sepsis or septic shock. Volume 
responsive patients SVV > 13% receive volume therapy titrated against both SVV and SVI. 
For non-volume responsive patients, the physiology is interrogated at the level of cardiac 
performance on a beat to beat basis. Ultimately and with this approach rapidly a majority 
of patients will develop a SVI > normal (pathway 1). This represents resuscitated septic 
shock and these patients may be safely placed on a vasopressor, knowing that volume 
resuscitation has been accomplished. Precise volume titration can be maintained but once 
SVI is supraphysiologic (pathway 3) volume therapy is stopped and diuretics might be 
warranted for that population who go on to develop ALI/ARDS typically after the initial 
resuscitation phase. Approaches to the patient in pathway 2 will be discussed in the text 
(McGee, 2009). 
2.4 Assessment of oxygen delivery 
Non-volume responsive patients (SVV < 13%) with low SVI or CO are a particularly 
challenging population. DO2 adequacy must be determined on an individual basis. This 
will also apply to some patients with normal SVI or CO. O2 extraction is particularly 
useful in this regard facilitating determination of the adequacy of bulk oxygen transport. 
When extraction is low or normal (<33%) augmentation of DO2 has not been shown to be 
helpful. (Gattinoni, 1995, Hayes 1994) Alternatively, high extraction (>40%) usually 
precipitates some attempt at DO2 optimization, although this approach has not been 
rigorously evaluated, it remains the basis of all resuscitation strategies. It is clear that as 
O2 extraction increases, physiologic reserve is compromised, lactic acidosis ensues, and 
mortality results. Using O2 extraction as an endpoint further refines hemodynamic care of 
this severely ill group of patients and is the physiologic foundation of early goal directed 
therapy. 
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Fig. 7. 
 
 
Fig. 8. 
www.intechopen.com
Applied Physiology and the Hemodynamic Management of  
Septic Shock Utilizing the Physiologic Optimization Program 
 
267 
For those patients with extraction greater than normal but not excessively elevated (>33% to 
< 40%). Best clinical management remains unclear. DO2 should be determined as a first step. 
Clinical assessment of physiology as it relates to the individual patient along with frequent 
reassessment of other clinical parameters would typically lead to a watchful waiting 
approach or more aggressive resuscitation. (Figure 8) 
O2 extraction data helps assess the adequacy of O2 delivery. If adequate (extraction <33%) a 
vasopressor depending on the blood pressure or no further therapy is generally appropriate. 
Other possible interventions are shown in Figure 8, all titrated against a change in 
SVI/cardiac output and ultimately oxygen delivery.  
In applying these algorithms at the bedside, the use of sound physiologic principles guides 
management in a group of patients in whom advanced hemodynamic monitoring can be 
easily and safely obtained (McGee, 2009). 
2.5 Total physiologic assessment for septic shock 
When possible but especially for those patients in whom we desire a more complete picture 
of cardiac performance typically those with normal or decreased stroke volume/cardiac 
output; echocardiography with assessment of biventricular function and ventricular 
interdependence along with pulmonary artery pressure allows for a complete description of 
cardiac performance and suggests possible therapies for augmentation if necessary. 
Inotropes for pure left ventricular failure or diagnosis and treatment of impairment of left 
ventricular filling from right ventricular distension as two common examples of how this 
additional cardiac functional anatomic data refines clinical care. Numerous other etiologies 
are possible and beyond the scope of this manuscript, but functional biventricular 
assessment is perhaps the final piece to a complete hemodynamic assessment of the 
critically ill septic shock patient. Flow (SV/CO and DO2), preload responsiveness 
(SVV/PPV), perfusion (ScVO2 and calculation of O2 extraction) along with biventricular 
function (echo) can all be obtained reasonably safely for a majority of critically ill patients 
who routinely have arterial and central venous catheters and often have echocardiography 
performed. 
Goal directed therapy saves lives of patients with severe sepsis. Application of physiology 
based volume management for the care of these patients further refines therapy while 
providing assurance that preload optimization is accomplished while minimizing the 
impact of excess volume. Titrated hemodynamic management using applied physiology has 
further potential to improve outcomes over more traditional approaches to the management 
of severe sepsis and septic shock. 
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